Skip to content
Taxonomy
Alliance Partner NMD Pharma A/S Launches Phase II SYNAPSE-CMT Trial with First Patient Dosed at CMTA Center of Excellence
The Charcot-Marie-Tooth Association (CMTA) congratulates CMTA-STAR Alliance Partner NMD Pharma Read More
CMTA-INC Strategic Alliance Announces the 2025 Inherited Neuropathy Fellowship
The Charcot-Marie-Tooth Association (CMTA), through its strategic alliance with the Read More
CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types
CMTA strengthens its role as the leading force in comprehensive Read More
Advancements in CMT1A and CMT1B Research Highlight CMTA’s Impact
Exciting news from a CMTA-STAR-funded research project has been published Read More
Gene Therapy for CMT1A, 1B, and X1: Progress in Nanoparticles
In a jointly-funded project between CMTA and the Muscular Dystrophy Read More
Progress Update: Timmerman’s CMT1A Organoid Project Shows Early Success
CMTA is excited to report significant progress in its strategic Read More
Breakthrough in CMT1A Research: Community Efforts Drive Success of Dental Stem Cell Model
With the incredible support of the CMT community, Esther Wolfs, Read More
CMTA Partners with Actio Bio on CMT2C Focus Group
The Charcot-Marie-Tooth Association (CMTA), in collaboration with Actio Biosciences (Actio Read More
The Charcot-Marie-Tooth Association Launches Gadget Store
THE CHARCOT-MARIE-TOOTH ASSOCIATION LAUNCHES AMAZON STOREFRONT FEATURING ASSISTIVE GADGETS & Read More
CMT2F Natural History Study Nears Full Recruitment as Biomarker Analysis Begins
With CMTA support of $302,071, an international team of researchers Read More
